Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat

PHASE3CompletedINTERVENTIONAL
Enrollment

269

Participants

Timeline

Start Date

December 4, 2006

Primary Completion Date

November 15, 2007

Study Completion Date

November 15, 2007

Conditions
Pharyngitis
Interventions
DRUG

Celecoxib

dose 1 celecoxib 50 mg followed 6-12 hours later by dose 2 celecoxib 50 mg

DRUG

Celecoxib

dose 1 celecoxib 100 mg followed 6-12 hours later by dose 2 placebo

DRUG

celecoxib

dose 1 celecoxib 100 mg followed 6-12 hours later by dose 2 celecoxib 50 mg

DRUG

placebo

dose 1 placebo followed 6-12 hours later by dose 2 placebo

Trial Locations (1)

06269-2011

University of Connecticut Student Health Services, Storrs

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00402987 - Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat | Biotech Hunter | Biotech Hunter